Skip to main content
Top
Published in: Virology Journal 1/2023

Open Access 01-12-2023 | Human Papillomavirus | Research

Peripheral blood lymphocytes influence human papillomavirus infection and clearance: a retrospective cohort study

Authors: Ye Li, Yebin Feng, Yanlin Chen, Wenyu Lin, Hangjing Gao, Ming Chen, Kelvin Stefan Osafo, Xiaodan Mao, Yafang Kang, Leyi Huang, Dabin Liu, Shuxia Xu, Lixiang Huang, Binhua Dong, Pengming Sun

Published in: Virology Journal | Issue 1/2023

Login to get access

Abstract

Background

There is a close correlation between HPV infection and systemic immune status. The purpose of this study was to determine which lymphocytes in peripheral blood influence human papillomavirus (HPV) infection and to identify whether peripheral blood lymphocyte (PBL) subsets could be used as biomarkers to predict HPV clearance in the short term.

Methods

This study involved 716 women undergoing colposcopy from 2019 to 2021. Logistic and Cox regression were used to analyze the association of PBLs with HPV infection and clearance. Using Cox regression, bidirectional stepwise regression and the Akaike information criterion (AIC), lymphocyte prediction models were developed, with the C-index assessing performance. ROC analysis determined optimal cutoff values, and their accuracy for HPV clearance risk stratification was evaluated via Kaplan‒Meier and time-dependent ROC. Bootstrap resampling validated the model and cutoff values.

Results

Lower CD4 + T cells were associated with a higher risk of HPV, high-risk HPV, HPV18 and HPV52 infections, with corresponding ORs (95% CI) of 1.58 (1.16–2.15), 1.71 (1.23–2.36), 2.37 (1.12–5.02), and 3.67 (1.78–7.54), respectively. PBL subsets mainly affect the natural clearance of HPV, but their impact on postoperative HPV outcomes is not significant (P > 0.05). Lower T-cell and CD8 + T-cell counts, as well as a higher NK cell count, are unfavorable factors for natural HPV clearance (P < 0.05). The optimal cutoff values determined by the PBL prognostic model (T-cell percentage: 67.39%, NK cell percentage: 22.65%, CD8 + T-cell model risk score: 0.95) can effectively divide the population into high-risk and low-risk groups, accurately predicting the natural clearance of HPV. After internal validation with bootstrap resampling, the above conclusions still hold.

Conclusions

CD4 + T cells were important determinants of HPV infection. T cells, NK cells, and CD8 + T cells can serve as potential biomarkers for predicting natural HPV clearance, which can aid in patient risk stratification, individualized treatment, and follow-up management.
Appendix
Available only for authorised users
Literature
5.
go back to reference Conceição Gomes Nascimento K, Gonçalves Lima É, Mota Nunes Z, Rêgo Barros Júnior M, de Aragão Batista MV, Lucena Araujo AR, da, Costa Silva Neto J, Simas Chagas B, Almeida Diniz Gurgel AP, de Freitas AC. Detection of Human Papillomavirus DNA in Paired Peripheral Blood and Cervix Samples in Patients with Cervical Lesions and Healthy Individuals. Journal of Clinical Medicine. 2021; 10:5209. https://doi.org/10.3390/jcm10215209. Conceição Gomes Nascimento K, Gonçalves Lima É, Mota Nunes Z, Rêgo Barros Júnior M, de Aragão Batista MV, Lucena Araujo AR, da, Costa Silva Neto J, Simas Chagas B, Almeida Diniz Gurgel AP, de Freitas AC. Detection of Human Papillomavirus DNA in Paired Peripheral Blood and Cervix Samples in Patients with Cervical Lesions and Healthy Individuals. Journal of Clinical Medicine. 2021; 10:5209. https://​doi.​org/​10.​3390/​jcm10215209.
12.
go back to reference Lukesova E, Boucek J, Rotnaglova E, Salakova M, Koslabova E, Grega M, Eckschlager T, Rihova B, Prochazka B, Klozar J et al. High level of Tregs is a positive prognostic marker in patients with HPV-positive oral and oropharyngeal squamous cell carcinomas. BioMed Research International. 2014; 2014:303929. https://doi.org/10.1155/2014/303929. Lukesova E, Boucek J, Rotnaglova E, Salakova M, Koslabova E, Grega M, Eckschlager T, Rihova B, Prochazka B, Klozar J et al. High level of Tregs is a positive prognostic marker in patients with HPV-positive oral and oropharyngeal squamous cell carcinomas. BioMed Research International. 2014; 2014:303929. https://​doi.​org/​10.​1155/​2014/​303929.
13.
go back to reference Spivak M, Lakatosh VP, Lazarenko LM, Lyanenko LM, Azarskova MV, Mikhailenko OM, Tkáciková L, Boroda AM. Interrelation of lymphocyte subpopulations in peripheral blood under cervical papillomavirus infection. Folia Microbiol. 1999;44:721–5. https://doi.org/10.1007/BF02825669.CrossRef Spivak M, Lakatosh VP, Lazarenko LM, Lyanenko LM, Azarskova MV, Mikhailenko OM, Tkáciková L, Boroda AM. Interrelation of lymphocyte subpopulations in peripheral blood under cervical papillomavirus infection. Folia Microbiol. 1999;44:721–5. https://​doi.​org/​10.​1007/​BF02825669.CrossRef
14.
go back to reference Lazarenko L, Spivak M, Lakatosh V, Kryvokhatska L, Mikhailenko O, Rudenko A, Tkáciková L, Mikula I. Production of interferons and change of the lymphocyte subpopulation phenotype in peripheral blood at cervical papillomavirus infection. Folia Microbiol. 2002;47:747–52. https://doi.org/10.1007/BF02818683.CrossRef Lazarenko L, Spivak M, Lakatosh V, Kryvokhatska L, Mikhailenko O, Rudenko A, Tkáciková L, Mikula I. Production of interferons and change of the lymphocyte subpopulation phenotype in peripheral blood at cervical papillomavirus infection. Folia Microbiol. 2002;47:747–52. https://​doi.​org/​10.​1007/​BF02818683.CrossRef
20.
go back to reference Welters MJP, van der Logt P, van den Eeden SJF, Kwappenberg KMC, Drijfhout JW, Fleuren GJ, Kenter GG, Melief CJM, van der Burg SH, Offringa R. Detection of human papillomavirus type 18 E6 and E7-specific CD4 + T-helper 1 immunity in relation to health versus disease. Int J Cancer. 2006;118:950–6. https://doi.org/10.1002/ijc.21459.CrossRefPubMed Welters MJP, van der Logt P, van den Eeden SJF, Kwappenberg KMC, Drijfhout JW, Fleuren GJ, Kenter GG, Melief CJM, van der Burg SH, Offringa R. Detection of human papillomavirus type 18 E6 and E7-specific CD4 + T-helper 1 immunity in relation to health versus disease. Int J Cancer. 2006;118:950–6. https://​doi.​org/​10.​1002/​ijc.​21459.CrossRefPubMed
22.
24.
go back to reference Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih Y-CT, Walter LC et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA: a Cancer Journal For Clinicians. 2020; 70:321–346. https://doi.org/10.3322/caac.21628. Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih Y-CT, Walter LC et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA: a Cancer Journal For Clinicians. 2020; 70:321–346. https://​doi.​org/​10.​3322/​caac.​21628.
28.
go back to reference Jimenez-Perez MI, Jave-Suarez LF, Ortiz-Lazareno PC, Bravo-Cuellar A, Gonzalez-Ramella O, Aguilar-Lemarroy A, Hernandez-Flores G, Pereira-Suarez AL, Daneri-Navarro A, del Toro-Arreola S. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications. BMC Immunol. 2012;13:7. https://doi.org/10.1186/1471-2172-13-7.CrossRefPubMedPubMedCentral Jimenez-Perez MI, Jave-Suarez LF, Ortiz-Lazareno PC, Bravo-Cuellar A, Gonzalez-Ramella O, Aguilar-Lemarroy A, Hernandez-Flores G, Pereira-Suarez AL, Daneri-Navarro A, del Toro-Arreola S. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications. BMC Immunol. 2012;13:7. https://​doi.​org/​10.​1186/​1471-2172-13-7.CrossRefPubMedPubMedCentral
Metadata
Title
Peripheral blood lymphocytes influence human papillomavirus infection and clearance: a retrospective cohort study
Authors
Ye Li
Yebin Feng
Yanlin Chen
Wenyu Lin
Hangjing Gao
Ming Chen
Kelvin Stefan Osafo
Xiaodan Mao
Yafang Kang
Leyi Huang
Dabin Liu
Shuxia Xu
Lixiang Huang
Binhua Dong
Pengming Sun
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2023
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-023-02039-6

Other articles of this Issue 1/2023

Virology Journal 1/2023 Go to the issue